Orionis Biosciences, Inc
20Patents
20Active
20Granted
47Portfolio score
Filing activity: Nov 7, 2016 → Oct 5, 2022
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11236166B2 | CD8 binding agents | Emerging Cross-Sectional Technologies | 6 | Active |
| US11001631B2 | Clec9A binding agents | Emerging Cross-Sectional Technologies | 5 | Active |
| US10906985B2 | Targeted engineered interferon and uses thereof | Chemistry; Metallurgy | 4 | Active |
| US10988538B2 | Bispecific signaling agents and uses thereof | Emerging Cross-Sectional Technologies | 4 | Active |
| US11084859B2 | Targeted mutant interferon-gamma and uses thereof | Emerging Cross-Sectional Technologies | 4 | Active |
| US11236141B2 | Targeted mutant interferon-beta and uses thereof | Emerging Cross-Sectional Technologies | 3 | Active |
| US11661455B2 | Chimeric protein comprising an interferon alpha 2mutant and a PD-L1 binding moiety | Chemistry; Metallurgy | 1 | Active |
| US11384154B2 | Targeted chimeric proteins and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US11498966B2 | PD-1 and PD-L1 binding agents | Chemistry; Metallurgy | 0 | Active |
| US11702477B2 | Bi-functional chimeric proteins and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US12351614B2 | CLEC9A-based chimeric protein complexes | Chemistry; Metallurgy | 0 | Active |
| US11566072B2 | CD8 binding agents | Chemistry; Metallurgy | 0 | Active |
| US11753463B2 | Therapeutic targeting of non-cellular structures | Chemistry; Metallurgy | 0 | Active |
| US12351633B2 | PD-1 and PD-L1 binding agents | Chemistry; Metallurgy | 0 | Active |
| US12364753B2 | CD8 binding agents | Emerging Cross-Sectional Technologies | 0 | Active |
| US11896643B2 | Fibroblast binding agents and use thereof | Chemistry; Metallurgy | 0 | Active |
| US12091463B2 | Clec9A binding agents comprising a recombinant heavy-chain only antibody (VHH) | Chemistry; Metallurgy | 0 | Active |
| US11440943B2 | Therapeutic interferon alpha 1 proteins | Chemistry; Metallurgy | 0 | Active |
| US12410225B2 | Modulation of dendritic cell lineages | Chemistry; Metallurgy | 0 | Active |
| US12084497B2 | SIRP1α targeted chimeric proteins and uses thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.